Alliance Pharma plc (AIM:APH)
64.60
+0.20 (0.31%)
Apr 25, 2025, 5:15 PM GMT+1
Alliance Pharma Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 32.36 | 22.44 | 31.71 | 29.06 | 28.9 | Upgrade
|
Cash & Short-Term Investments | 32.36 | 22.44 | 31.71 | 29.06 | 28.9 | Upgrade
|
Cash Growth | 44.23% | -29.25% | 9.13% | 0.56% | 62.08% | Upgrade
|
Accounts Receivable | 45.54 | 49.37 | 44.76 | 25.75 | 19.83 | Upgrade
|
Other Receivables | 0.8 | 2.32 | 3.47 | 1.97 | 4.38 | Upgrade
|
Receivables | 46.34 | 51.69 | 48.23 | 27.72 | 24.22 | Upgrade
|
Inventory | 22.52 | 25.71 | 24.29 | 21.08 | 22.92 | Upgrade
|
Prepaid Expenses | 3.04 | 3.03 | 1.09 | 3.1 | 0.9 | Upgrade
|
Other Current Assets | 0.07 | 1.23 | 0.16 | 0.06 | 0.31 | Upgrade
|
Total Current Assets | 104.33 | 104.1 | 105.48 | 81.02 | 77.24 | Upgrade
|
Property, Plant & Equipment | 5.25 | 5.48 | 5.24 | 4.46 | 4.49 | Upgrade
|
Goodwill | 12.75 | 14.49 | 14.7 | 31.24 | 31.26 | Upgrade
|
Other Intangible Assets | 241.05 | 285.74 | 379.02 | 382.87 | 393.04 | Upgrade
|
Long-Term Deferred Tax Assets | 5.65 | 4.65 | 4.12 | 3.53 | 2.14 | Upgrade
|
Other Long-Term Assets | 0.12 | 0.48 | 0.61 | 0.37 | 0.68 | Upgrade
|
Total Assets | 369.14 | 414.92 | 509.15 | 503.49 | 508.85 | Upgrade
|
Accounts Payable | 13.7 | 18.23 | 18.57 | 8.34 | 11.28 | Upgrade
|
Accrued Expenses | 17.49 | 17.37 | 15.52 | 20.29 | 16.08 | Upgrade
|
Current Portion of Leases | 0.6 | 0.77 | 0.61 | 0.46 | 0.96 | Upgrade
|
Current Income Taxes Payable | 2.74 | 2.45 | 2.98 | 1.18 | 1.44 | Upgrade
|
Other Current Liabilities | 2.17 | 1.76 | 9.34 | 10.32 | 0.43 | Upgrade
|
Total Current Liabilities | 36.69 | 40.57 | 47.02 | 40.58 | 30.19 | Upgrade
|
Long-Term Debt | 92.48 | 113.65 | 133.74 | 116.06 | 138.33 | Upgrade
|
Long-Term Leases | 2.62 | 3 | 3.22 | 2.43 | 2.73 | Upgrade
|
Long-Term Deferred Tax Liabilities | 28.75 | 37.86 | 59.46 | 61.73 | 56.18 | Upgrade
|
Other Long-Term Liabilities | 0.96 | 1.97 | 0.2 | 0.21 | 0.47 | Upgrade
|
Total Liabilities | 161.5 | 197.05 | 243.64 | 221 | 227.9 | Upgrade
|
Common Stock | 5.41 | 5.4 | 5.4 | 5.38 | 5.33 | Upgrade
|
Additional Paid-In Capital | 151.7 | 151.68 | 151.65 | 151.33 | 150.65 | Upgrade
|
Retained Earnings | 32.64 | 43.37 | 86.09 | 116.42 | 117.7 | Upgrade
|
Comprehensive Income & Other | 17.9 | 17.42 | 22.37 | 9.36 | 7.28 | Upgrade
|
Shareholders' Equity | 207.64 | 217.87 | 265.52 | 282.49 | 280.96 | Upgrade
|
Total Liabilities & Equity | 369.14 | 414.92 | 509.15 | 503.49 | 508.85 | Upgrade
|
Total Debt | 95.7 | 117.42 | 137.58 | 118.94 | 142.02 | Upgrade
|
Net Cash (Debt) | -63.34 | -94.98 | -105.86 | -89.88 | -113.13 | Upgrade
|
Net Cash Per Share | -0.12 | -0.18 | -0.20 | -0.17 | -0.21 | Upgrade
|
Filing Date Shares Outstanding | 541.37 | 540.4 | 540 | 538.23 | 532.92 | Upgrade
|
Total Common Shares Outstanding | 540.57 | 540.39 | 540 | 538.23 | 532.92 | Upgrade
|
Working Capital | 67.64 | 63.53 | 58.46 | 40.44 | 47.05 | Upgrade
|
Book Value Per Share | 0.38 | 0.40 | 0.49 | 0.52 | 0.53 | Upgrade
|
Tangible Book Value | -46.15 | -82.35 | -128.2 | -131.63 | -143.34 | Upgrade
|
Tangible Book Value Per Share | -0.09 | -0.15 | -0.24 | -0.24 | -0.27 | Upgrade
|
Machinery | 5.35 | 4.62 | 4.02 | 3.8 | 2.54 | Upgrade
|
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.